




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領
文檔簡介
1、Chapter 38Macrolides, Lincomycins and Polymycins大環(huán)內(nèi)酯類藥物14元大環(huán)內(nèi)酯類:紅霉素、羅紅霉素、克拉霉素、地紅霉素15元大環(huán)內(nèi)酯類:阿奇霉素16元大環(huán)內(nèi)酯類:螺旋霉素、乙酰螺旋霉素、麥迪霉素、麥白霉素、羅他霉素、柱晶白霉素、交沙霉素、米歐卡霉素Macrolides First generation : 1950serythromycinSecond generation:1970sclaithromycin azithromycinThird generation:Common properties of MacrolidesAntibacte
2、rial activityFirst generationMost G+ organisms: pneumococci, streptococci, staphylococci , diphtheriae etcPart G- organisms:legionella軍團菌,bacillus pertussis(百日咳), brucella(布氏) etcOthers: mycoplasma(支原體), chlamydia trachomatis(沙眼衣原體), rickettsia(立克次體), spirochete ,anaerobes etc. Second generationMore
3、 active on G- organismsMechanism of actionTarget 50s ribosomal RNAMechanism inhibition of translocation of mRNAMechanism of resistanceProduction of inactivating enzymesModification of the ribosomal binding siteActive efflux systemMLSRPharmokinetics AbsorptionErythromycin: not stable at acid pHNew ma
4、crolides: stable poDistribution Metabolism: Erythromycin&clarithromycin: in liverExcretion Erythromycin& azithromycin: bileClarithromycin: kidneyCommomly used macrolidesErythromycin Antimicrobial activityGram-positive organisms: pneumococci, streptococci, staphylococci , diphtheriae etcGram-negative
5、 organisms:legionella軍團菌,bacillus pertussis(百日咳), brucella(布氏) , meningococci, diplococcus gonorrhoeae etcOthers: mycoplasma(支原體), chlamydia trachomatis(沙眼衣原體), rickettsia(立克次體), spirochete ,anaerobes etc. ErythromycinClinical uses As penicillin substitute in penicillin-allergic or resistant patient
6、s with infections caused by staphylococci, streptococci and pneumococciPertussis,diphtheriaeLegionella and mycoplasma pneumoniaH.p infectionErythromycinAdverse reactionsGastrointestinal effectsLiver toxicityCardiotoxicity Erythromycin Erythromycin lactobionate(乳糖酸紅霉素erythromycin estolate無味紅霉素)erythr
7、omycin stearate(硬脂酸紅霉素erythromycin ethylsuccinate琥乙紅霉素, 利君沙 New macrolides antibioticsAdvantage :Broader spectrum, higher activityOrally effectiveHigh blood concentrationLonger t 1/2Less toxicityMainly used in respiratory tract infectionClarithromycin甲紅霉素,克拉霉素Has the strongest activity on Gram-posit
8、ive bacteria, legionella pneumophila, chlamydia pneumoniaeGood pharmacokinetic propertyLow toxicityAzithromycin (阿齊霉素,麗珠奇樂Has the strongest activity against mycoplasma pneumoniae肺炎支原體More effective on Gram-negative bacteriaWell toleratedT1/2 :3548h once dailyMainly used in respitory tract infectionR
9、oxithromycin 羅紅霉素,嚴迪 1987 FranceThe highest blood concentration F 72%85%Respiratory tract infection and soft tissue infectionLow adverse effectsLincomycin and ClindamycinAntimicrobial activityGram-positive organismsBacteroide fragilis and other anaerobesMechanism Binding to 50s ribosome subunit and
10、inhibiting protein synthesisPharmacokineticsAbsorbed wellPenetrate well into most tissues including bone ClindaycinClinical uses Severe anaerobic infection Acute or chronical suppurative osteomylitis , arthritis caused by susceptive organisms especially Staphylococci aureusAdverse reactionsGastroint
11、estinal effects: severe diarrhea and pseudomembranous enterocolitis caused by Clostridium difficile :vancomycin & metronidazoleOther :Impaired liver function , neutropeniaPolypeptide antibioticsVancomycin & TeicoplaninPolymyxinsbactitracinVancomycin Mechanism of actionInhibit cell wall synthesisAnti
12、microbial spectrum:Narrow spectrum, active only against gram-positive bacteria paticularly staphylococciPharmacokineticsPoorly absorbed from intestinal tract, ivExcreted from glomerular filtration 90%VancomycinClinical uses Infection caused by MRSA, MRSE and penicillin-resistant pneumococcusTreatmen
13、t of antibiotic-associated enterocolitis caused by clostridium difficile poAdverse reactionOtotoxicity & nephrotoxicityRed-man syndromeTeicoplanin Similar to vancomycin in mechanism and antimicrobial spectrumCan be given im as well as ivLess adverse reactionsPolymyxins Active only against gram-negative rods, particularly P.aeruginosaMechanism:increase permeability of cell membraneMainly used in P.aeruginosa infection when other dr
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 實習教師協(xié)議合同
- 股東向公司借款協(xié)議合同
- 二零二五版二手房買賣合同范文匯編
- 二零二五舞蹈教師聘用合同范文
- 聘用聘請合同模板
- 鄉(xiāng)村全科助理醫(yī)師考試臨床應用分析試題及答案
- 酒店銷售流程管理制度
- 鍛造生產(chǎn)倉庫管理制度
- 銷售公司作風管理制度
- 健康管理制度系統(tǒng)圖
- 《融媒體實務》教學課件(全)
- 牛津譯林版六年級下冊英語期中檢測試卷+答案
- 重慶農(nóng)藝師考試(種植業(yè)卷)
- GB/T 32120-2022鋼結(jié)構(gòu)氧化聚合型包覆腐蝕控制技術(shù)
- 散文閱讀理解文中重要句子的含意公開課一等獎市優(yōu)質(zhì)課賽課獲獎課件
- 2023學年完整公開課版《認識洗衣機》
- 單層廠房課程設計-金屬結(jié)構(gòu)車間雙跨等高廠房
- 熱力管道裝置工程施工記錄表
- 特殊過程焊接工藝確認
- 企業(yè)信譽自查承諾書范文
- 平移和旋轉(zhuǎn)的應用
評論
0/150
提交評論